If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 552.00
Bid: 554.40
Ask: 554.80
Change: 3.80 (0.69%)
Spread: 0.40 (0.072%)
Open: 549.60
High: 555.20
Low: 549.20
Prev. Close: 548.20
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Succession and Board Update

15 Sep 2022 08:20

RNS Number : 5717Z
B&M European Value Retail S.A.
15 September 2022
 

 

 

15 September 2022

B&M European Value Retail S.A.

 

Management Succession and Board Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, announced on 31 May 2022 that Alex Russo (currently Group Chief Financial Officer "CFO") would succeed Simon Arora as Group Chief Executive Officer ("CEO"). The Group today confirms that Alex will become CEO on 26 September 2022, the commencement of the second half of the Group's financial year. At that point Simon Arora, who announced his intention to step down as CEO on 22 April 2022, will retire as CEO but continue to serve the Board as an Executive Director until the end of his notice period in April 2023.

 

Mike Schmidt, who was previously announced as the successor to Alex Russo in the role of CFO, will join the business on 17 October 2022. In the short period between Alex's appointment as CEO taking effect on 26 September 2022 and Mike joining as CFO on 17 October 2022, Alex will retain responsibility for his current role and will be supported in that work by Peter Waterhouse as Group Financial Controller.

 

On 18 August 2022, the Group announced that Ron McMillan (currently Senior Independent Director and Chair of the Audit and Risk Committee) would be retiring as a Director at the conclusion of the Company's AGM in July 2023 and that Oliver Tant would be appointed to the Board in November 2022 and would succeed Ron as Chair of the Audit and Risk Committee when he retires from the Board. The Group now confirms that Tiffany Hall, currently Non-Executive Director and Chair of the Remuneration Committee, will become Senior Independent Director when Ron retires from the Board.

 

Since there is currently no vacancy in the office of a Director, in accordance with Luxembourg law, Mike Schmidt's and Oliver Tant's appointments to the Board are required to be approved by resolutions of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders will be convened for 31 October 2022 (the "Meeting") for that purpose. Subject to their appointments being approved at the Meeting, both appointments to the Board will take effect on 1 November 2022. Further announcements will be made to confirm when the notice of the Meeting has been sent to shareholders and, following the Meeting, to confirm the outcomes of the votes.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation. There is no further information to be disclosed in accordance with Listing Rule 9.6.13.

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext. 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALAMFTMTBBMLT
Date   Source Headline
18th Jan 202211:11 amRNSHolding(s) in Company
18th Jan 202211:01 amRNSDirector/PDMR Shareholding
14th Jan 20227:00 amRNSResult of Secondary Placing of Ordinary Shares
13th Jan 20224:45 pmRNSProposed Secondary Placing of Ordinary Shares
13th Jan 20221:05 pmRNSBlock listing Interim Review
6th Jan 20227:00 amRNSQ3 FY22 Trading Update
30th Dec 20214:58 pmRNSPost Stabilisation Notice
9th Dec 20217:00 amRNSSpecial Dividend
24th Nov 202111:02 amRNSDirector/PDMR Notice
17th Nov 20213:48 pmRNSPricing of Senior Secured Notes Offering
15th Nov 20218:16 amRNSLaunch of Senior Secured Notes Offering
11th Nov 20217:00 amRNSFY22 Interim Results
10th Nov 20214:19 pmRNSHolding(s) in Company
10th Nov 202111:42 amRNSResult of Ordinary General Meeting
30th Sep 20219:00 amRNSTotal Voting Rights
30th Sep 20219:00 amRNSOrdinary General Meeting
16th Sep 20219:26 amRNSDirector/PDMR Shareholding
8th Sep 20219:36 amRNSTrading Update
12th Aug 20217:00 amRNSBoard Appointment
4th Aug 20218:00 amRNSBlock Listing Application
3rd Aug 202111:12 amRNSDirector/PDMR Shareholding
2nd Aug 202110:32 amRNSTotal Voting Rights
29th Jul 202112:16 pmRNSResult of AGM
20th Jul 202112:35 pmRNSDirector Declaration
16th Jul 20218:00 amRNSDirector/PDMR Shareholding
14th Jul 202111:22 amRNSDirector/PDMR Shareholding
13th Jul 20219:00 amRNSBlock listing Interim Review
8th Jul 20217:00 amRNSTrading Statement
21st Jun 20217:00 amRNSAnnual Financial Report
3rd Jun 20217:00 amRNSBoard Change
3rd Jun 20217:00 amRNSPreliminary Results
15th Mar 202110:16 amRNSHolding(s) in Company
4th Mar 20217:00 amRNSTrading Update
1st Mar 20219:48 amRNSTotal Voting Rights
25th Feb 20219:20 amRNSDirector Declaration
22nd Feb 20215:06 pmRNSDirector/PDMR Securities
10th Feb 20212:16 pmRNSHolding(s) in Company
9th Feb 202110:05 amRNSHolding(s) in Company
27th Jan 20217:00 amRNSHolding(s) in Company
20th Jan 20213:17 pmRNSHolding(s) in Company
20th Jan 202111:02 amRNSHolding(s) in Company
15th Jan 20214:02 pmRNSHolding(s) in Company
14th Jan 202112:52 pmRNSDirector/PDMR Shareholding
13th Jan 20219:24 amRNSBlock listing Interim Review
12th Jan 202110:00 amRNSDirector Declaration
12th Jan 20217:00 amRNSResults of Placing
11th Jan 20215:22 pmRNSProposed Secondary Placing
7th Jan 20217:00 amRNSTrading Statement
29th Dec 20209:25 amRNSDirector/PDMR Securities
29th Dec 20209:18 amRNSDirector/PDMR Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.